Methylphenidate for attention problems in epilepsy patients: Safety and efficacy.
Methylphenidate for attention problems in epilepsy patients: Safety and efficacy.
复制标题
哌甲酯治疗癫痫患者的注意力问题:安全性和有效性。
DOI:
10.1016/j.yebeh.2020.107627
复制
发表时间:
2021-03
期刊:
影响因子:
--
通讯作者:
Meador KJ
中科院分区:
文献类型:
--
作者:
Leeman-Markowski BA;Adams J;Martin SP;Devinsky O;Meador KJ
Children with attention deficit hyperactivity disorder (ADHD) have an increased risk of seizures, and children with epilepsy have an increased prevalence of ADHD. Adults with epilepsy often have varying degrees of attentional dysfunction due to multiple factors, including antiseizure medications, frequent seizures, interictal discharges, underlying lesions, and psychiatric comorbidities. Currently, there are no approved medications for the treatment of epilepsy-related attentional dysfunction. Methylphenidate (MPH) is a stimulant, FDA-approved for the treatment of ADHD, and often used for ADHD in the setting of pediatric epilepsy. Large database and registry studies indicate safety of MPH in children with ADHD and epilepsy, with no significant effect on seizure frequency. Small single-dose and open-label studies suggest efficacy of MPH in adults with epilepsy-related attention deficits. MPH represents a possible treatment for attentional dysfunction due to epilepsy, but large, randomized, placebo-controlled, double-blinded studies are needed.
登录
查看更多内容
影响因子:
3.7
作者:
Chou IC;Chang YT;Chin ZN;Muo CH;Sung FC;Kuo HT;Tsai CH;Kao CH
通讯作者:
Kao CH
影响因子:
3.6
作者:
Conners, CK;Epstein, JN;Klaric, J
通讯作者:
Klaric, J
影响因子:
2.6
作者:
Ashjazadeh, Nahid;Sahraeian, Ali;Asadi-Pooya, Ali A.
通讯作者:
Asadi-Pooya, Ali A.
影响因子:
4.7
作者:
Corbisiero, Salvatore;Bitto, Hannes;Stieglitz, Rolf-Dieter
通讯作者:
Stieglitz, Rolf-Dieter
影响因子:
38.1
作者:
Bell, Brian;Lin, Jack J.;Seidenberg, Michael;Hermann, Bruce
通讯作者:
Hermann, Bruce